Clinical Impact of TP53 Gene Mutations in Diffuse Large B-Cell Lymphoma (DLBCL): An International DLBCL Rituxan-CHOP Consortium Program Study
- Møller, M. B. (Speaker)
Activity: Talks and presentations › Talks and presentations in private or public companies